ClinicalTrials.gg
Active, not recruitingNCT07269418ORACLEUpdated Dec 8, 2025

Optimization of Conoid Anatomical Reconstruction During Ligamentoplasty for Acromioclavicular Disjunction

An observational study in Acromioclavicular; Dislocation and Ligament Repair or Reconstruction, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Active, not recruiting at 1 site in France. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-12-08.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
36
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This is a prospective, longitudinal, multicenter, observational cohort study conducted on a population of patients who underwent ligamentoplasty for an acromioclavicular dislocation and who agreed to be followed for a period of two years starting from the day of hospital discharge.

Read the detailed description

The objective of this study is purely observational. This study modifies the normal doctor-patient relationship due to the need for additional evaluations aimed at assessing the long-term functional outcome of the intervention through the administration of questionnaires.

The study will be carried out in five centers : the Clinique de l'Union in Toulouse (Saint-Jean), the Niçois Institute of Sport and Arthrosis in Nice, the Confluent Private Hospital in Nantes, the Clinique du Cap d'Or in La Seyne-sur-Mer and the Savoie Metropole Hospital Center in Chambéry.

02

Conditions studied

  • Acromioclavicular; Dislocation
  • Ligament Repair or Reconstruction

Browse trials for

Keywords

  • anatomic ligament reconstruction
  • acromioclavicular disjunction
03

In context

Joint Dislocations

98 studies on the registry are indexed under Joint Dislocations; 21 are open to participants now.

This study's enrollment of 36 is below the median of 100 across 37 observational studies indexed under Joint Dislocations.

Browse Joint Dislocations studies →

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 207 studies on the registry; 99 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patient operated on for anatomic ligament reconstruction for an acromioclavicular disjunction

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female aged 18 to 60
  • Patient who has been informed of the objectives and conditions of the study and who has not objected to participation
  • Patient who has undergone reconstruction for an acute Rockwood stage 4 or 5 acromioclavicular dislocation and for whom elbow immobilization was required for 6 weeks (self-rehabilitation in the supine position is possible from day 15, without pendulum or adduction movements).

Exclusion criteria

Exclusion Criteria:

  • Time between trauma and ACL reconstruction greater than 10 days
  • History of surgery or trauma to the operated shoulder
  • History of acromioclavicular surgery or trauma to the contralateral shoulder
  • History of shoulder stiffness
  • Patient playing a contact sport (rugby, American football)
  • Presence of severe acromioclavicular osteoarthritis
  • Mental impairment or any other reason that may hinder understanding or strict application of the protocol
  • Patient under legal protection, guardianship, or curatorship
  • Patient already included in an interventional therapeutic trial
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
36 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Acromioclavicular reduction

    The parameters measured and compared with the contralateral side will be : * The CC (coracoclavicular) distance measured on the anteroposterior Zanca view * The AC-DC distance(Acromial center line to dorsal clavicle) * The GC-PC distance (Glenoid center line to posterior clavicle) Assessment of the result of the intervention on the acromioclavicular radiological reduction 3 months post-operatively according to the quantitative radiographic parameters described by Zumstein. The reduction will be considered as: * Complete if the AC-DC and GC-PC distances on the operated side are equal to those on the healthy side, with a margin of less than 10%. * Partial if the AC-DC and GC-PC distances on the operated side are equal to those on the healthy side, with a margin between 10% and 20%. * Poor if the AC-DC and GC-PC distances on the operated side are equal to those on the healthy side, with a margin greater than 20%.

    Time frame: Month 3

Secondary outcomes

  1. Pain assessement

    Progression of pain with the Self-Constant score. Self-Constant score explores several domains such as pain, activity, strength, and mobility(functional evaluation) : * Pain is assessed using a numerical scale ranging from 0 (no pain) to 10 (unbearable pain) * Professional and leisure activities are evaluated by the patient using a numerical scale ranging from 0 (no activities possible) to 10 (all activities possible) * Mobility: the ranges to be considered are those that are possible actively and without pain. Active anterior elevation, active abduction, and active external rotation are evaluated by the patient with reference to photographs showing the different levels of range of motion * Muscle strength is evaluated according to the patient's ability to lift a certain number of common objects (from a 500 g can to a 9 kg pack of water) The total score ranges from 0 to 100 points, with 100 indicating a normal shoulder and 0 indicating a completely deficient shoulder

    Time frame: Month 24

  2. Shoulder functional assessment with the the ACJI Score (Acromioclavicular Joint Instability Score)

    Describe, over the 2 years following surgery, changes in shoulder function scores: The ACJI Score (Acromioclavicular Joint Instability Score) assesses acromioclavicular joint instability across five dimensions: * Spontaneous pain and pain on palpation (out of 20 points) * Activities of daily living (out of 10 points) * Aesthetics (out of 10 points) * Function (out of 25 points), including evaluation of range of motion (flexion, abduction, external rotation, internal rotation) and abduction strength at 90° abduction * Radiological findings (out of 35 points): post-traumatic osteoarthritis, vertical stability, and horizontal stability The final score ranges from 0 to 100, with 0 corresponding to almost no function and 100 to normal function.

    Time frame: Month 3

  3. Return to work

    Time to return to work after discharge from hospital

    Time frame: Month 24

  4. Resumption of physical and sporting activities (with the Self-Constant score)

    Describe, over the 2 years following the intervention, the time and level of resumption of physical and sporting activities with Self-Constant score ranges from 0 (deficient shoulder) to 100 (normal shouder). Self-Constant score explores several domains such as pain, activity, strength, and mobility (functional evaluation): * Pain is assessed using a numerical scale ranging from 0 (no pain) to 10 (unbearable pain) * Professional and leisure activities are evaluated by the patient using a numerical scale ranging from 0 (no activities possible) to 10 (all activities possible) * Mobility: the ranges to be considered are those that are possible actively and without pain. Active anterior elevation, active abduction, and active external rotation are evaluated by the patient with reference to photographs showing the different levels of range of motion * Muscle strength is evaluated according to the patient's ability to lift a certain number of common objects (from 500g can to 9kg pack of water)

    Time frame: Month 24

  5. Patient satisfaction

    Overall Assessment of Patient Satisfaction : Patient satisfaction with their care and outcomes will be assessed at the end of the study on a simple numerical scale ranging from 0 (very dissatisfied) to 10 (very satisfied).

    Time frame: Month 24

  6. Shoulder Functional assessment with the SSV Score (Subjective Shoulder Value Score)

    Describe, over the 2 years following surgery, changes in shoulder function scores : The SSV Score (Subjective Shoulder Value Score) is a subjective assessment score that allows the patient to evaluate the value of their affected shoulder compared to a completely healthy shoulder. The result is expressed as a percentage (between 0 % and 100%, 0 is an anormal function and 100% a normal function of the shoulder).

    Time frame: Month 24

  7. Resumption of physical and sporting activities with the ACJI score

    Describe, over the 2 years following the intervention, the time and level of resumption of physical and sporting activities with the ACJI score (acromioclavicular joint instability score). The ACJI Score (Acromioclavicular Joint Instability Score) assesses acromioclavicular joint instability across five dimensions: * Spontaneous pain and pain on palpation (out of 20 points) * Activities of daily living (out of 10 points) * Aesthetics (out of 10 points) * Function (out of 25 points), including evaluation of range of motion (flexion, abduction, external rotation, internal rotation) and abduction strength at 90° abduction * Radiological findings (out of 35 points): post-traumatic osteoarthritis, vertical stability, and horizontal stability The final score ranges from 0 to 100, with 0 corresponding to almost no function and 100 to normal function.

    Time frame: Month 3

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07269418
Responsible party
Sponsor
First posted
Dec 8, 2025
Start date
Mar 28, 2024
Primary completion
Mar 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Dec 8, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion